nmri nude mice (Taconic Biosciences)
Taconic Biosciences is a verified supplier 
93
Structured Review
Taconic Biosciences
nmri nude mice
Nmri Nude Mice, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 102 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmri+nude+mice/NMRI+nude/us12589171-189-37-42
Average 93 stars, based on 102 article reviews
Nmri Nude Mice, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 102 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmri+nude+mice/NMRI+nude/us12589171-189-37-42
Average 93 stars, based on 102 article reviews
nmri nude mice - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6 high uterine leiomyosarcoma to PD‐1 blockade Article Snippet: Tumour tissue fragments from PDX tumours were implanted interscapularly in female Article Title: Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth Article Snippet: 6-week-old Radioactivity:Article Title: Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules Article Snippet: .. Brigimadlin bound fraction was calculated using the following equation: Cdon = radioactivity/brigimadlin concentration in the donor chamber (plasma compartment) at equilibrium don accdon C CC 100 (%) fB compartment) at equilibrium fB = protein bound fraction in plasma (%) fU = protein unbound fraction in plasma (%) Cell- and patient-derived xenograft model studies Pharmacodynamic (PD) biomarker studies to measure serum growth/differentiation factor15 [GDF15/MIC-1] and tumor GDF15 mRNA were performed in female Concentration Assay:Article Title: Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules Article Snippet: .. Brigimadlin bound fraction was calculated using the following equation: Cdon = radioactivity/brigimadlin concentration in the donor chamber (plasma compartment) at equilibrium don accdon C CC 100 (%) fB compartment) at equilibrium fB = protein bound fraction in plasma (%) fU = protein unbound fraction in plasma (%) Cell- and patient-derived xenograft model studies Pharmacodynamic (PD) biomarker studies to measure serum growth/differentiation factor15 [GDF15/MIC-1] and tumor GDF15 mRNA were performed in female Clinical Proteomics:Article Title: Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules Article Snippet: .. Brigimadlin bound fraction was calculated using the following equation: Cdon = radioactivity/brigimadlin concentration in the donor chamber (plasma compartment) at equilibrium don accdon C CC 100 (%) fB compartment) at equilibrium fB = protein bound fraction in plasma (%) fU = protein unbound fraction in plasma (%) Cell- and patient-derived xenograft model studies Pharmacodynamic (PD) biomarker studies to measure serum growth/differentiation factor15 [GDF15/MIC-1] and tumor GDF15 mRNA were performed in female Biomarker Discovery:Article Title: Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules Article Snippet: .. Brigimadlin bound fraction was calculated using the following equation: Cdon = radioactivity/brigimadlin concentration in the donor chamber (plasma compartment) at equilibrium don accdon C CC 100 (%) fB compartment) at equilibrium fB = protein bound fraction in plasma (%) fU = protein unbound fraction in plasma (%) Cell- and patient-derived xenograft model studies Pharmacodynamic (PD) biomarker studies to measure serum growth/differentiation factor15 [GDF15/MIC-1] and tumor GDF15 mRNA were performed in female Injection:Article Title: 177-Lu labeled peptide for site-specific uPAR-targeting Article Snippet: .. The intra-cardiac dissemination model was established by injection of 20 μl cells (105 cells/ml) in the left ventricle in male Article Title: 177-Lu labeled peptide for site-specific uPAR-targeting Article Snippet: .. Xenografts of human HT-29 colorectal cancer cells was established by injection of 200 μl cells (1×108 cells/ml) suspended in 100 μl Matrigel (BD Biosciences, San Jose, CA, USA), subcutaneously in the left and right flank of female Article Title: Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET Article Snippet: .. Eight week In Vivo:Article Title: Supporting Information Optimization of PDE3A Modulators for SLFN12-dependent Cancer Cell Killing Article Snippet: .. In vivo xenograft model The antitumor efficacy and tolerability of (R)-30 was evaluated in the SK-MEL-3 human melanoma cell line-derived xenograft model in female |